Literature DB >> 14524419

Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling.

Lalage M Wakefield1, Gudmundur Thordarson, Ana I Nieto, G Shyamala, Jose J Galvez, Miriam R Anver, Robert D Cardiff.   

Abstract

The FVB/N mouse strain is widely used in the generation of transgenic mouse models. We have observed that mammary glands of wild-type virgin female FVB/NCr mice frequently have the morphologic and histologic appearance of a gland during pregnancy. By 13 months of age, the mammary glands of more than 40% of the mice examined had lobuloalveolar hyperplasia that was characterized by the presence of secretory alveoli and distended ducts apparently containing secretory material. The prevalence of this phenotype further increased with age. The mammary phenotype was highly correlated with the presence of proliferative, prolactin-secreting lesions in the pituitary gland. In mice aged 18 to 23 months, hyperplasia of the pars distalis was seen in 11 of 21 mice (52%), and a further 4 of 21 mice (19%) had pituitary adenomas. Pituitary hyperplasia was already evident in some mice as young as nine months. The pituitary phenotype was also associated with high prevalence (4/6 mice) of spontaneous mammary tumors in aged multiparous, but not virgin FVB/NCr mice. This high prevalence of pituitary abnormalities and their effects on the mammary gland have important consequences for the interpretation of new phenotypes generated in transgenic models using this mouse substrain.

Entities:  

Mesh:

Year:  2003        PMID: 14524419

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  18 in total

1.  Bisphenol A increases mammary cancer risk in two distinct mouse models of breast cancer.

Authors:  Kristen Weber Lozada; Ruth A Keri
Journal:  Biol Reprod       Date:  2011-06-02       Impact factor: 4.285

Review 2.  The genomic revolution and endocrine pathology.

Authors:  Suzana S Couto; Robert D Cardiff
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

3.  Post-transcriptional mechanisms contribute to the suppression of the ErbB3 negative regulator protein Nrdp1 in mammary tumors.

Authors:  Ellen Q Ingalla; Jamie K Miller; Jessica H Wald; Heather C Workman; Rouminder P Kaur; Lily Yen; William H D Fry; Alexander D Borowsky; Lawrence J T Young; Colleen Sweeney; Kermit L Carraway
Journal:  J Biol Chem       Date:  2010-07-13       Impact factor: 5.157

4.  Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2.

Authors:  Robert K Dearth; Xiaojiang Cui; Hyun-Jung Kim; Isere Kuiatse; Nicole A Lawrence; Xiaomei Zhang; Jana Divisova; Ora L Britton; Syed Mohsin; D Craig Allred; Darryl L Hadsell; Adrian V Lee
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

5.  CrkII transgene induces atypical mammary gland development and tumorigenesis.

Authors:  Kelly E Fathers; Sonia Rodrigues; Dongmei Zuo; Indrani Vasudeva Murthy; Michael Hallett; Robert Cardiff; Morag Park
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

6.  Histopathologic findings and establishment of novel tumor lines from spontaneous tumors in FVB/N mice.

Authors:  Peigen Huang; Dan G Duda; Rakesh K Jain; Dai Fukumura
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

7.  Cystic mammary adenocarcinoma associated with a prolactin-secreting pituitary adenoma in a New Zealand white rabbit (Oryctolagus cuniculus).

Authors:  Paul Sikoski; James Trybus; J Mark Cline; F Salih Muhammad; Andrew Eckhoff; Josh Tan; Mandy Lockard; Tammy Jolley; Susan Britt; Nancy D Kock
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

8.  Mammary tumorigenesis following transgenic expression of a dominant negative CHK2 mutant.

Authors:  Eunice L Kwak; Sang Kim; Jianmin Zhang; Robert D Cardiff; Emmett V Schmidt; Daniel A Haber
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

Review 9.  Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression.

Authors:  Kay-Uwe Wagner; Hallgeir Rui
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-29       Impact factor: 2.673

10.  Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition.

Authors:  Erica L McCoy; Ritsuko Iwanaga; Paul Jedlicka; Nee-Shamo Abbey; Lewis A Chodosh; Karen A Heichman; Alana L Welm; Heide L Ford
Journal:  J Clin Invest       Date:  2009-08-24       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.